Furthermore, this establishes that the observed inverse relationships of GLD with lipid and glucose traits are not driven by the medication usage, even though medications such as statins can alter GLD through its impacts on HMGCR, which in turn may explain impacts on T2D risk. The gene discussed is HMGCR; the disease is type 2 diabetes mellitus.